Phocas Financial Corp’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.81M	Sell	81,347 -22,725	-22%	-$543K	0.28%	114
2025 Q4	$2.78M	Sell	104,072 -271	-0.3%	-$6.48K	0.36%	101
2025 Q3	$2.23M	Buy	104,343 +2,167	+2%	+$51.2K	0.29%	109
2025 Q2	$2.2M	Buy	102,176 +15	+0%	+$279	0.32%	100
2025 Q1	$1.7M	Sell	102,161 -5,650	-5%	-$103K	0.26%	107
2024 Q4	$1.98M	Buy	107,811 +47,596	+79%	+$768K	0.26%	112
2024 Q3	$926	Sell	60,215 -3,782	-6%	-$63.1K	﹤0.01%	138
2024 Q2	$1.04K	Sell	63,997 -1,210	-2%	-$19.5K	﹤0.01%	133
2024 Q1	$1.21K	Sell	65,207 -1,750	-3%	-$43.4K	﹤0.01%	138
2023 Q4	$2.1M	Buy	66,957 +1,266	+2%	+$30.2K	0.28%	115
2023 Q3	$1.37M	Buy	+65,691	New	+$1.78M	0.2%	120